APP and Alzheimer disease: Although APP-overexpressing transgenic mice have been important tools in AD research, concerns exist regarding the interference of the unphysiologically high levels of APP and its proteolytic fragments (which are not increased in AD in humans) with normal brain function, and the creation of artificial phenotypes [30, 31].